Montelukast in the treatment of asthma
and allergic rhinitis

Helen Neighbour1, Andrew McIvor

Asthma and allergic rhinitis are common diseases that impact a large number

of people worldwide. Safe and effective treatments are needed to reduce the morbidity and,

in asthma, the mortality associated with them. In this article, we review the use of a leukotriene

receptor antagonist, montelukast, in the treatment of these conditions. This article provides an

overview of the pharmacology of montelukast and the guidline recommendations for its use in

asthma and allergic rhinitis.

:

Pratique clinique